



© Authors; 2019. International Journal of Clinical and Biomedical Research, Sumathi Publications.  
This is an Open Access article which permits unrestricted non-commercial use, provided the original work is properly cited.  
(CC BY-NC-SA 4.0) 
INTRODUCTION 
Epilepsy is characterized by the presence of recurrent 
seizures. A seizure can be defined as “an episodic 
disturbance of movement, feeling, or consciousness 
caused by sudden synchronous, inappropriate, and 
excessive electrical discharges in the cerebral 
cortex” [1]. Epileptic convulsions are expected to have 
negative consequences on the patient’s psychological 
and social life such as relationships, education and 
employment. Uncontrolled seizures are associated with 
physical and psychosocial morbidity, dependent 
behaviour, poor quality of life and an increased risk of 
sudden unexpected death. Therefore, it is often 
recommended to begin treatment of epilepsy with 
antiepileptic drugs (AEDs) as soon as the patient has 
reported more than one documented or witnessed 
seizure bearing in mind that the goal of treatment should 
be to maintain as normal a life style through complete 
seizure control with no or minimal side effects [2]. 
Anti-convulsant drugs are widely used in the treatment 
of various central nervous system diseases like bipolar 
disorder, antipsychotic, impulsive aggression, 
borderline personality disorder etc. Benzothiazepine is 
the most vital class of series origin of benzodiazepine 
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pharmacophore. They are differ only in place of sulphur 
and nitrogen element in the heterocyclic ring system. 
Particularly benzothiazepines used as a cardiovascular-
related diseases vix coronary vasodilation, hypertension 
etc. Recently it has been used as a anti-convulsant, 
antipsychotic activity, anti-HIV activity, antimicrobial 
activity etc. There are various benzothiazepines which 
have been synthesized and tested for their biological 
activities (3-6). 1,5 benzothiazepine is a calcium 
channel blocker also known as Diltiazem [3]. Diltiazem 
is a non-dihydropyridine (DHP) member of the group of 
drugs known as benzothiazepine. 
Medicinal chemists today are facing many complicated 
challenges. The most demanding and perhaps the most 
rewarding one is the rational design of new therapeutic 
agents for treating human diseases. The definition 
currently accepted of what molecular modelling can be 
stated as “molecular modelling is anything that requires 
the use of a computer to paint, describe or evaluate any 
aspect of the properties of the structure of a molecule”. 
Methods used in the molecular modelling are regarding 
automatic structure generation, analysis of three-
dimensional (3D) databases and construction of protein 
models by techniques based on sequence homology, 
diversity analysis, docking of ligand. Molecular 
modelling has widened the horizons of pharmaceutical 
research by providing tools for finding new leads. 
Thus, today, molecular modelling is regarded as a field 
concerned with the use of all sort of different strategies 
to model and to deduce information of a system at the 
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atomic level. On the other hand, this discipline includes 
all methodologies used in computational chemistry, like 
computation of the energy of a molecular system, 
energy minimisation Monte Carlo methods or molecular 
dynamics. In other words, it is possible to conclude that 
computational chemistry is the nucleus of molecular 
modelling. Identification of bio-molecular moieties 
involved in the interaction with a specific receptor 
permits to understand the molecular mechanism 
responsible of its particular biological activity. In turn, 
this knowledge is aimed at designing new active 
molecules that can be successfully used as drugs. 
Because simulation accuracy is limited to the precision 
of the constructed models, when it is possible, 
computational simulations have to be compared with 
experimental results to confirm model accuracy and to 
modify them if necessary, in order to obtain better 
representations of the system [4-6]. 
The developments of new anti-convulsant therapeutic 
agents are one of the fundamental goals in medicinal 
chemistry. In recent years there has been concerned 
search for the discovery and development of potent and 
selective against anti-convulsant agents. Heterocyclic 
compounds comprise the dominant family of organic 
compounds. These are enormously essential with a wide 
range of synthetic, pharmaceutical and industrial 
applications and are famous for their biological 
activities. There is an extensive spectrum of biological 
activities shown by many compounds containing five-
membered heterocyclic rings in their structure.  
Therefore we attempt to identify the potential molecule 
for the synthesis of 1,5-benzothiazepine as an 
anticonvulsant using V-Life MDS 4.3 software for the 
execution of synthesis of selected moiety. From the 
present work, we find out the physicochemical and 
interactive parameters responsible for the anticonvulsant 
action of new 1,5-benzothiazepine as anti-convulsant 
agents from the docking studies,  
MATERIAL AND METHODOLOGY    
Equipments: All computational studies were performed 
using V-Life Molecular Design Software Version 4.3. 
Docking study were generated using a training set of 
300 molecules. 
Molecular docking studies: V Life MDS version 4.3 
software was employed to assess the structure of the 
enzyme-inhibitor complex. In our study, three series of 
1,5 benzothiazepine were selected for docking studies 
(Figure 1a, 1b and 1c)  Three hundred structure of 1,5-
benzothiazepine expected derivatives were tested and 
also shown in Table 1, 2 and 3.VLifeMDS version 4.3 
expected binding free energies of enzyme-inhibitor 
complexes and the binding energies of both the bound 
and unbound states using semi-empirical free energy 
force field. The 3D structures of following PDBs were 
acquired from RCSB Protein Data Bank. The PDB id is, 
3IP9 (Structure of Atu2422-GABA receptor in complex 
with GABA shown in Figure 2) [7]. The 3D structures 
of selected 1,5-benzothiazepine derivatives were drawn 
in ACD-Chemsketch and converted into 3D mol. 
format. The automated docking model was generated 
using Vlife MDS Tool. The co-crystallized ligand was 
used to generate the grid box for catalytic inhibition 
mode. The selected grid box size was 60×60×60. 
PyMOL 1.7.4 and LigPlot+ were adopted to acquire the 
number of H-bonds and van der Waals interacting 
residues. To determine the binding affinities between 
the ligand and receptor, the amino acids with the 
binding pockets was predicted at Q-site finder server 
[8]. 
RESULTS  
Fig 1. Selected 1,5-benzothiazepine series for the 
docking study 
Fig 2. Target structure PDB code 3IP9 (Structure of 
Atu2422-GABA receptor in complex with GABA) 
Docking Study: Molecular docking approach was utilze 
to guess the enzyme inhibitor interaction geometrics for 
the selected compounds. The docking scores for 1,5-
benzothiazepine derivatives (selected 300 substituents 
on 1,5-benzothiazepine moieties) with interacting 3IP9 
(Structure of Atu2422-GABA receptor in complex with 
GABA) residues including hydrogen bond, van der 
Waals and hydrophobic interacting residues. Sodium 
Phenytoin moiety was choose as a standard drug for the 
docking study. 
DISCUSSION 
Epilepsy is an associated with physical and 
psychosocial morbidity, dependent behavior, poor 
quality of life and an increased risk of sudden 
unexpected death , therefore  it an urgent social need to 
discover a new potential derivative for the treatment of 
epilepsy. Henceforth we have planned to synthesized 
new derivative from the class of 1,5 benzothizepine. 
Generally we have drawn the three series for the 
synthesis of 1,5 benzothizepine moiety to get higher 
potential moiety. Three hundred substituents of the 
selected series were fixed and were screened to get 
better activity against the epilepsy. As per the 
discussion in introduction part molecular modeling 
study is the best option to get the idea about potency of 
Int. j. clin. biomed. res. 2019;5(3):29-36. 
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Fig 3. 2D images of 1a-10ainteract  
with 3IP9 protein 
Fig 4. 2D images of 101b-110b bonding with 3IP9 
protein 
Fig 5. 2D images of 201C-210C bonding  
with 3IP9 protein 
Simta et al.   Silico design of potential 1,5-benzothiazepine derivatives as an anti-convulsant agent. 











Compound Code R1 R2 R3 Compound Code R1 R2 R3 
 1 H OH H  51 I Br CH3 
 2 H OCH3 H  52 I Cl CH3 
 3 H Cl H  53 I NO2 CH3 
 4 H F H  54 I NH2 CH3 
 5 H Br H  55 I NH2 I 
 6 OH Br H  56 I NH2 F 
 7 OH Br OH  57 I NH2 Br 
 8 H NO2 H  58 I NH2 NO2 
 9 Cl H H  59 I NH2 NH2 
 10 F H H  60 F NH2 F 
 11 Br H H  61 F NO2 F 
 12 OH H H  62 F I F 
 13 OH I H  63 F Cl F 
 14 OH Cl H  64 F Br F 
 15 OH F H  65 F NH-CH3 F 
 16 H NO2 H  66 I NH-CH3 F 
 17 Br NO2 H  67 Br NH-CH3 F 
 18 F NO2 H  68 H NH-CH3 F 
 19 NO2 NO2 H  69 H NH-CH3 H 
 20 OH NO2 H  70 H NH-CH3 OH 
 21 OH NO2 Cl  71 H NH-CH3 CH3 
 22 OH NO2 F  72 H NH-CH3 I 
 23 OH NO2 Br  73 H NH-CH3 Cl 
 24 OH NO2 NO2  74 H NH-CH3 Br 
 25 OH NO2 I  75 NO2 NH-CH3 Br 
 26 OH H H  76 NO2 NH-CH3 F 
 27 H H H  77 NO2 CH2-CH3 CH3 
 28 OH CH3 CH3  78 NH2 CH2-CH3 CH3 
 29 CH3 H H  79 F CH2-CH3 CH3 
 30 CH3 H Br  80 I CH2-CH3 CH3 




































 37 CH3 NO2 CH3  87 Cl C=O H 
 38 CH3 NO2 H  88 H C=O H 
 39 CH3 NO2 Cl  89 Br C=O H 
 40 CH3 NO2 F  90 OH C=O H 
 41 CH3 NO2 Br 91 I C=O H 
 42 CH3 CH3 H  92 NO2 C=O H 
 43 CH3 CH3 CH3  93 F C=O H 
 44 Cl CH3 CH3  94 NH2 C=O H 
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pound Code R1 R2 R3 R4 
Compound 
Code R1 R2 R3 R4 














 151 H F CH3 NH2 
 102 H OCH3 OH 152 H Cl CH3 NH2 
 103 H Cl OH  153 H Br CH3 NH2 
 104 H I OH  154 H NO2 CH3 NH2 
 105 H F OH  155 H NH2 CH3 NH2 
 106 H -CH2-CH3 OH  156 H CH3 CH3 NH2 
 107 H Br OH  157 H CH2-CH3 CH3 NH2 
 108 H NO2 OH  158 OH NH-CH3 CH3 NH2 
 109 H NH2 OH  159 H NH-CH3 CH3 NH2 
 110 H CH3 OH  160 OH NH-I CH3 NH2 
 111 OH Cl OH  161 OH NH-F CH3 NH2 
 112 H CH3 Br  162 OH NH-Br CH3 NH2 
 113 H NH2 Br NH2  163 OH I NH2 NH2 
 114 H NO2 Br NH2  164 OH F NH2 NH2 
 115 H Br Br NH2  165 OH Cl NH2 NH2 
 116 H Cl Br NH2  166 OH Br NH2 NH2 
 117 H F Br NH2  167 OH CH3 NH2 NH2 
 118 H I Br NH2  168 OH NO2 NH2 NH2 
 119 H I NO2 NH2  169 OH NH2 NH2 NO2 
 120 H F NO2 NH2  170 OH NH-CH3 NH2 NO2 
 121 H Cl NO2 NH2  171 OH NH-CH3 NO2 NO2 
 122 H Br NO2 NH2  172 OH CH2-CH3 NO2 NO2 
 123 H CH3 Cl NH2  173 OH CH3 NO2 NO2 
 124 H NH2 Cl NH2  174 OH NH2 NO2 NO2 
 125 H NO2 Cl NH2  175 OH NO2 NO2 NO2 
 126 H Br Cl NH2  176 OH CH3  H 










 128 H F Cl NH2  178 OH -CH2-CH3 H 
 129 H I Cl NH2  179 OH -CH2-NH2 H 
 130 H I F NH2  180 OH NH-CH3 NH2 
 131 H F F NH2  181 OH NH2 H 
 132 H Cl F NH2  182 OH Br H 
 133 H Br F NH2  183 OH Cl H 
 134 H NO2 F NH2  184 OH F H 
 135 H NH2 F NH2  185 OH I H 
 136 H CH3 F NH2  186 OH I NH2 
 137 H -CH2-CH3 I NH2  187 NH2 I H H 
 138 H CH3 I NH2  188 NH2 F H H 





 140 H NH2 I NH2  190 H NH-CH3 NH2 
 141 H Br I NH2  191 CH3 NH2 NH2 
 142 H Cl I NH2  192 CH3 NH-CH3 H NH2 
 143 H F I NH2  193 CH3 NH-CH3 CH3 NH2 





 194 CH3 NH-CH3 CH2Cl NH2 
 145 H CH2I OH  195 CH3 NH-CH3 CH2Br NH2 
 146 H CH2F OH  196 CH3 NH-CH3 CH2I NH2 
 147 H CH2Cl OH  197 CH3 NH-CH3 CH2NH2 NH2 
 148 H CH2Br OH  198 CH3 NH-CH3 CH2NO2 NH2 
 149 H CH2 NO2 OH NH2  199 Cl NH2 H NH2 
 150 H CH2NH2 OH NH2  200 Cl NH-NH2 CH-2 NH2 
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Compound Code R1 R2 R3 Compound Code R1 R2 R3 
 201 OCH3 H H  251 CH3 H NH2 
 202 OCH3 OCH3 H  252 CH3 H CH3 
 203 OCH3 NO2 H  253 CH3 H CH2-CH3 
 204 H I H  254 CH3 H CH2-NO2 
 205 H F H  255 CH3 H CH2-NH2 
 206 H Br H  256 CH3 H H 
 207 H NO2 H  257 CH3 H OH 
 208 H NH2 H  258 CH3 H NH2 
 209 H CH3 H  259 H H CH3 
 210 H CH2-CH3 H  260 OH H CH3 
 211 I CH2-CH3 H  261 CH3 NH2 H 
 212 I CH3 H  262 CH3 NO2 H 
 213 I NO2 H  263 CH3 Br H 
 214 I NH2 H  264 CH3 Cl H 
 215 I Br H  265 CH3 F H 
 216 I Cl H  266 CH3 I H 
 217 I F H  267 CH3 H I 
 218 I I H  268 CH3 H Br 
 219 F I H  269 CH3 H F 
 220 F F H  270 CH3 H NO2 
 221 F Cl H  271 NH2 NO2 H 
 222 F Br H  272 NH2 NH2 H 
 223 F NO2 H  273 NH2 CH3 H 
 224 F NH2 H  274 NH2 CH2-CH3 H 
 225 F CH3 H  275 NH2 CH2-NH2 H 
 226 F CH2-CH3 H  276 NH2 CH2-NO2 H 
 227 Cl CH2-CH3 H  277 CH3 CH2-NO2 H 
 228 Cl CH2-NH2 H  278 CH3 CH2-NH2 H 
 229 Cl CH3 H  279 CH3 CH2-CH2-NH2 H 
 230 Cl NH2 H  280 CH3 CH3 H 
 231 Cl NO2 H  281 NO2 I H 
 232 Cl Br H  282 NO2 F H 
 233 Cl Cl H  283 NO2 Cl H 
 234 Cl F H  284 NO2 Br H 
 235 Cl I H  285 NO2 NH2 H 
 236 Br I H  286 NO2 NO2 H 
 237 Br F H  287 NH2 I CH3 
 238 Br NH2 H  288 NH2 F CH3 
 239 Br Cl H  289 NH2 Cl CH3 
 240 Br Br H  290 NH2 Br CH3 
 241 Br NO2 H  291 Br CH2-NO2 CH3 
 242 Br OCH3 H  292 Br CH2-NH2 CH3 
 243 Br CH2-CH3 H  293 NO2 CH2-NO2 CH3 
 244 OCH3 CH2-CH3 H  294 NO2 CH2-NH2 CH3 
 245 OCH3 NO2 H  295 NO2 CH3 CH3 
 246 OCH3 CH3 H  296 NO2 CH2-CH2-NH2 CH3 
 247 OCH3 F H  297 Br CH2-CH3 CH3 
 248 OCH3 I H  298 Br CH3 CH3 
 249 OCH3 Cl H  299 Br NH2 CH3 
 250 OCH3 H H  300 Br NO2 CH3 
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A conserved mechanism of GABA binding and 
antagonism is revealed by Structure-Function Analysis 
of the periplasmic binding protein Atu2422 [7]. 
Bacterial periplasmic binding proteins (PBPs) and 
eukaryotic PBP-like domains (also called as Venus 
flytrap modules) of G-protein-coupled receptors are 
involved in extracellular GABA perception (8). Gamma 
- Aminobutyric acids (GABA), the prime inhibitory 
neurotransmitter in the cerebral cortex, sustain the 
inhibitory tenor that counterbalance neuronal excitation 
(9). Therefore we have targeted protein i.e 3IP9 
(Structure of Atu2422-GABA receptor in complex with 
GABA) is particularly found in GABA receptor as per 
the report of Planamente et al., (2010) [7].  
For checking binding interaction first open receptor in 
MDS followed by compound which saved as ligand 
dock file. From tool option click on merge molecule so 
that compound and receptoris merged together. From 
biopredicta tool edit this complex and select ligand and 
receptor structure afterward check its interaction. The 
said protein is correlates with anticonsulvant activity. 
To discuss the interaction details of ligands and protein, 
the docked conformations of the compounds were 
studied on 3IP9. The said proteins belong to the class of 
GABA receptor group of proteins, which exhibited 
structural stability to the gene and expression by 
epigenetic modification of DNA, plays significant role 
in epilepsy. It was noted that the docking score of 1a to 
101a, 101b to 200b and 201c to 300c was almost same 
as that of selected standard sodium phenytoin. Protein 
showed hydrogen bonding with some of the compound 













Fig 6. Docking 3D Images of 1A to 10A synthesized 
compounds 
Fig 7. Docking 3D Images of 101B to 110B synthe-
sized compounds 
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Docking analysis was utilized to predict the mechanism 
of action of the designed derivatives for anticonvulsant 
potential. All the molecules exhibited binding score in 
the range of -82.61 to -118.25 kcal/mol. Most active 
molecules from Series 1, 2 and 3 exhibited hydrogen 
bond interactions with LEU282B, LEU282B and 
LEU282B respectively. Also for the selected atandard 
sodium phenytoin showed the hydrogen bond 
interaction with LYS637A. The series 1 showed 
hydrophobic bonding interactions with VAL290B, 
VAL290B, GLY421B, LEU282B etc. and Vander 
Waals interactions with LEU282B, LEU282B, 
GLY283B, PHE 287B, PHE420B (Figure 3). The series 
2 compound showed hyrdrophobic bond interactions 
with GLY421B, PHE420B, VAL 290B, LYS 309B and 
also Van der Waals interactions with LYS439B, 
PHE287B, GLY283B, LEU282B, GLY515B (Figure 
4). The compound from series 3 showed hydrophobic 
interaction with VAL291B, VAL295B, GLY427B, 
LEU280B and Van der Waals interactions with 
LEU284B, LEU285B, GLY280B, PHE207B and 
PHE421B (Figure 5). Whereas standard sodium 
phenytoin exbited hydrophobic interaction with 
ALA549A (4.675), ASP593A (2.987), LYS647A 
(2.638) and Van der Waals interactions with SER528A 
(4.658), THR652A (1.675), GLU428A (3.293) and 
ASN55AA 2.105. 
From the series 1, ten derivatives are selected for the 
synthesis of 1,5 benzothiazepine class namely 1a to 10a. 
It was observed that the good docking score (Table 4). 
The docking posses with 3D picture are depicted in 
Figure 5. Whereas series 2 have also selected 10 
derivative to synthesize the compounds namely 101b to 
110b. 3D docking images are depicted in Figure 6. The 
best docking posses of the series 3 of 1, 5 
benzothiazepine have been showed in the Figure 7. 
Total 30 compound are having good score which have 
been selected for the synthesis namely 1a-10a, 101b-
110b and 201c to 210c. In the docking study their van. 
It was discovered that the potential of 1a-100a, 101b-
200b, 201c-300c and Sodium Phenytoin against 3IP9 
(Structure of Atu2422-GABA receptor in complex with 
GABA) was linked with the binding energy and the 
number of bonds formed at the catalytic site. It was 
noted that the hydrogen bond and hydrophobic 
interaction of 1a-100a, 101b-200b, 201c-300c and 
Sodium Phenytoin with proteins further stabilized the 
enzyme-inhibitor interaction. The 3IP9 had interaction 
with 1a-100a, 101b-200b, 201c-300c and Sodium 
Phenytoin through hydrogen bond, the hydrogen bond 
interaction of 1a-100a, Sodium Phenytoin with 3IP9 
proteins further stabilized the enzyme-inhibitor 
interaction due to amino acid. 
CONCLUSION 
In this present investigation, it was found that all 
projected moiety were statistically significant, therefore 
from above 2D/3D models it could be concluded that 
1,5 benzothiazepine derivatives are used to synthesize 
as anti-convulsant drugs. It was found that 1a-10a, 101b
-110b and 201c-210c having good docking score for 
synthesizing the derivatives. It was noted that the 
docking score of 1a to 10a, 101b to 110b and 201c to 
230c was almost same as that of selected standard 
sodium phenytoin. Protein showed hydrogen bonding 
with all synthesized compound showed potential against 
the epilepsy with GABAnergic mechanism. 
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